{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:42:20Z","timestamp":1789245740182,"version":"build-2803163510"},"reference-count":190,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Hemoglobinopathies are autosomal recessive disorders that occur when genetic mutations negatively impact the function of hemoglobin. Common hemoglobinopathies that are clinically significant include sickle cell disease, alpha thalassemia, and beta thalassemia. Advancements in disease-modifying and curative treatments for the common hemoglobinopathies over the past thirty years have led to improvements in patient quality of life and longevity for those who are affected. However, the diseases, their treatments and cures pose infertility risks, making fertility preservation counseling and treatment an important part of the contemporary comprehensive patient care. Sickle cell disease negatively impacts both male and female infertility, primarily by testicular failure and decreased ovarian reserve, respectively. Fertility in both males and females with beta thalassemia major are negatively impacted by iron deposition due to chronic blood transfusions. Hematopoietic stem cell transplant (HSCT) is currently the only curative treatment for SCD and transfusion dependent beta thalassemia. Many of the conditioning regimens for HSCT contain chemotherapeutic agents with known gonadotoxicity and whole-body radiation. Although most clinical studies on toxicity and impact of HSCT on long-term health do not evaluate fertility, gonadal failure is common. Male fertility preservation modalities that exist prior to gonadotoxic treatment include sperm banking for pubertal males and testicular cryopreservation for pre-pubertal boys. For female patients, fertility preservation options include oocyte cryopreservation and ovarian tissue cryopreservation. Oocyte cryopreservation requires controlled ovarian hyperstimulation (COH) with ten to fourteen days of intensive monitoring and medication administration. This is feasible once the patient has undergone menarche. Follicular growth is monitored <jats:italic>via<\/jats:italic> transvaginal or transabdominal ultrasound, and hormone levels are monitored through frequent blood work. Oocytes are then harvested <jats:italic>via<\/jats:italic> a minimally invasive approach under anesthesia. Complications of COH are more common in patients with hemoglobinopathies. Ovarian hyperstimulation syndrome creates a greater risk to patients with underlying vascular, pulmonary, and renal injury, as they may be less able to tolerate fluids shifts. Thus, it is critical to monitor patients undergoing COH closely with close collaboration between the hematology team and the reproductive endocrinology team. Counseling patients and families about future fertility must take into consideration the patient\u2019s disease, treatment history, and planned treatment, acknowledging current knowledge gaps.<\/jats:p>","DOI":"10.3389\/fendo.2022.985525","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T10:39:07Z","timestamp":1666607947000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Fertility preservation for pediatric patients with hemoglobinopathies: Multidisciplinary counseling needed to optimize outcomes"],"prefix":"10.3389","volume":"13","author":[{"given":"Bronwyn S.","family":"Bedrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor P.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia H.","family":"Pecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy S.","family":"Christianson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-319-97873-4_3","article-title":"Red blood cell biochemistry and physiology","volume-title":"Concise guide to hematology","author":"van Beers","year":"2019"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1081\/HEM-100104027","article-title":"Databases of human hemoglobin variants and other resources at the globin gene server","volume":"25","author":"Hardison","year":"2001","journal-title":"Hemoglobin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull World Health Organ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202101190","article-title":"Sickle cell disease","volume":"174","author":"Pecker","year":"2021","journal-title":"Ann Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60283-3","article-title":"Thalassaemia","volume":"379","author":"Higgs","year":"2012","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.066845","article-title":"Non-transfusion-dependent thalassemias","volume":"98","author":"Musallam","year":"2013","journal-title":"Haematologica"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-697110","article-title":"An international registry of survivors with hb bart's hydrops fetalis syndrome","volume":"129","author":"Songdej","year":"2017","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05550.x","article-title":"The natural history of thalassemia intermedia","volume":"1202","author":"Borgna-Pignatti","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2008.tb01523.x","article-title":"Transfusion-dependent thalassaemia: a new era","volume":"188","author":"Berdoukas","year":"2008","journal-title":"Med J Aust"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18077","article-title":"Optimizing transfusion therapy for survivors of haemoglobin bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-h fraction and \"functional\" haemoglobin level","volume":"197","author":"Amid","year":"2022","journal-title":"Br J Haematol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.63.736.95","article-title":"Testicular dysfunction in men with sickle cell disease","volume":"63","author":"Osegbe","year":"1987","journal-title":"Postgrad Med J"},{"key":"B12","article-title":"The mechanism of low testosterone levels in homozygous sickle-cell disease","volume":"43","author":"Parshad","year":"1994","journal-title":"West Indian Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJM198407053110102","article-title":"Influence of sickle hemoglobinopathies on growth and development","volume":"311","author":"Platt","year":"1984","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-85-5-601","article-title":"Gonadal function abnormalities in sickle cell anemia. studies in adult male patients","volume":"85","author":"Abbasi","year":"1976","journal-title":"Ann Intern Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(80)90469-6","article-title":"Endocrine function and haemoglobinopathies: relation between the sickle cell gene and circulating plasma levels of testosterone, luteinising hormone (LH) and follicle stimulating hormone (FSH) in adult males","volume":"105","author":"Dada","year":"1980","journal-title":"Clin Chim Acta"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1159\/000337344","article-title":"Hypogonadism in patients with sickle cell disease: central or peripheral","volume":"128","author":"Taddesse","year":"2012","journal-title":"Acta Haematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1203\/pdr.0b013e318045bdca","article-title":"Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease","volume":"61","author":"Zemel","year":"2007","journal-title":"Pediatr Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12816","article-title":"Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors","volume":"12","author":"Anele","year":"2015","journal-title":"J Sex Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.00770.x","article-title":"Sickle cell disease status and outcomes of African-American men presenting with priapism","volume":"5","author":"Bennett","year":"2008","journal-title":"J Sex Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002062","article-title":"Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease","volume":"4","author":"Idris","year":"2020","journal-title":"Blood Adv"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)40809-5","article-title":"Testicular function in sickle cell disease","volume":"25","author":"Friedman","year":"1974","journal-title":"Fertil Steril"},{"key":"B22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0090-4295(03)00482-5","article-title":"Repeated testicular infarction in a patient with sickle cell disease: a possible mechanism for testicular failure","volume":"62","author":"Li","year":"2003","journal-title":"Urology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11515","article-title":"Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males","volume":"93","author":"Berthaut","year":"2008","journal-title":"Haematologica"},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1182\/blood-2020-143315","article-title":"Hydroxyurea use and outcomes of pregnancy in sickle cell disease","volume":"136","author":"Gordeuk","year":"2020","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1981.00340100051014","article-title":"Sexual development and fertility of Jamaican female patients with homozygous sickle cell disease","volume":"141","author":"Alleyne","year":"1981","journal-title":"Arch Intern Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/adc.85.5.375","article-title":"Sickle cell disease and age at menarche in Jamaican girls: observations from a cohort study","volume":"85","author":"Serjeant","year":"2001","journal-title":"Arch Dis Child"},{"key":"B27","article-title":"Growth and development in sickle cell anemia","volume":"4","author":"Luban","year":"1982","journal-title":"Preliminary Rep Am J Pediatr Hematol Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17658","article-title":"Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease","volume":"194","author":"Pecker","year":"2021","journal-title":"Br J Haematol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)37688-9","article-title":"Fertility in hemoglobin s-s and hemoglobin s-c disease","volume":"21","author":"Dunne","year":"1970","journal-title":"Fertil Steril"},{"key":"B30","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/17474086.2017.1367279","article-title":"Fertility challenges for women with sickle cell disease","volume":"10","author":"Ghafuri","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1258\/mi.2009.009015","article-title":"Ovarian sickling as a proposed mechanism for premature ovarian failure necessitating ovum donation","volume":"15","author":"Chase","year":"2009","journal-title":"Menopause Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bcmd.2015.03.012","article-title":"The effects of hydroxyurea and bone marrow transplant on anti-mullerian hormone (AMH) levels in females with sickle cell anemia","volume":"55","author":"Elchuri","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16976","article-title":"Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the multicenter study of hydroxycarbamide","volume":"191","author":"Pecker","year":"2020","journal-title":"Br J Haematol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012756","article-title":"Diminished ovarian reserve in young women with sickle cell anemia","volume":"139","author":"Pecker","year":"2022","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213024","article-title":"Ovarian reserve in women with sickle cell disease","volume":"14","author":"Kopeika","year":"2019","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13048-021-00927-5","article-title":"Ovarian reserve in nigerian women with sickle cell anaemia: a cross- sectional study","volume":"14","author":"Garba","year":"2021","journal-title":"J Ovarian Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.593718","article-title":"Consequences of beta-thalassemia or sickle cell disease for ovarian follicle number and morphology in girls who had ovarian tissue cryopreserved","volume":"11","author":"Mamsen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B38","article-title":"Endocrine complications in patients with thalassaemia major","volume":"5","author":"Toumba","year":"2007","journal-title":"Pediatr Endocrinol Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"617204","DOI":"10.1155\/2013\/617204","article-title":"Beta-thalassemia major and female fertility: the role of iron and iron-induced oxidative stress","volume":"2013","author":"Roussou","year":"2013","journal-title":"Anemia"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21670","article-title":"Pain as an emergent issue in thalassemia","volume":"85","author":"Trachtenberg","year":"2010","journal-title":"Am J Hematol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/2049463712438299","article-title":"Opioids and endocrine dysfunction","volume":"6","author":"Seyfried","year":"2012","journal-title":"Br J Pain"},{"key":"B42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jpain.2007.08.005","article-title":"Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain","volume":"9","author":"Daniell","year":"2008","journal-title":"J Pain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-69535-8_6","article-title":"Pain medications and Male reproduction","volume":"1034","author":"Drobnis","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/and.13026","article-title":"Tramadol (opioid) abuse is associated with a dose- and time-dependent poor sperm quality and hyperprolactinaemia in young men","volume":"50","author":"Farag","year":"2018","journal-title":"Andrologia"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225080-00001","article-title":"Nonsteroidal anti-inflammatory drugs and reversible female infertility: is there a link","volume":"25","author":"Stone","year":"2002","journal-title":"Drug Saf"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1530\/rep.1.01236","article-title":"Effects of selective inhibition of cyclooxygenase and lipooxygenase pathways in follicle rupture and ovulation in the rat","volume":"132","author":"Gaytan","year":"2006","journal-title":"Reproduction"},{"key":"B47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ajh.21117","article-title":"Stroke in thalassemia: a dilemma","volume":"83","author":"Taher","year":"2008","journal-title":"Am J Hematol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20402","article-title":"Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia","volume":"80","author":"Vichinsky","year":"2005","journal-title":"Am J Hematol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06332.x","article-title":"Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease","volume":"135","author":"Fung","year":"2006","journal-title":"Br J Haematol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199009133231104","article-title":"Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major","volume":"323","author":"Bronspiegel-Weintrob","year":"1990","journal-title":"N Engl J Med"},{"key":"B51","article-title":"The impact of iron overload and genotype on gonadal function in women with thalassaemia major","author":"Skordis","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-360271","article-title":"Reproductive capacity in iron overloaded women with thalassemia major","volume":"118","author":"Singer","year":"2011","journal-title":"Blood"},{"key":"B53","first-page":"295","article-title":"Pituitary siderosis. a histologic, immunocytologic, and ultrastructural study","volume":"93","author":"Bergeron","year":"1978","journal-title":"Am J Pathol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.83236","article-title":"Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients","volume":"5","author":"Abdulzahra","year":"2011","journal-title":"Asian J Transfus Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200311000-00011","article-title":"Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion-dependent beta-thalassemia","volume":"25","author":"Chern","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1365-2265.2000.00962.x","article-title":"Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload","volume":"53","author":"Chatterjee","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.41.2.133","article-title":"Gonadal function in patients with beta thalassaemia major","volume":"41","author":"De Sanctis","year":"1988","journal-title":"J Clin Pathol"},{"key":"B58","first-page":"296","article-title":"Update on fertility in thalassaemia major","author":"Skordis","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2003.16.6.877","article-title":"Inappropriate leptin secretion in thalassemia: a potential cofactor of pubertal timing derangement","volume":"16","author":"Perrone","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-002-0499-7","article-title":"Inverse correlation of plasma leptin and soluble transferrin receptor levels in beta-thalassemia patients","volume":"81","author":"Dedoussis","year":"2002","journal-title":"Ann Hematol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40738-020-00071-6","article-title":"Indicators of male fertility potential in adult patients with beta-thalassemia major: a comparative study between patients undergone allogeneic stem cell transplantation and transfusion-dependent patients","volume":"6","author":"Rostami","year":"2020","journal-title":"Fertil Res Pract"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.017228","article-title":"The life of patients with thalassemia major","volume":"95","author":"Borgna-Pignatti","year":"2010","journal-title":"Haematologica"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1772-4","article-title":"Gonadotropin replacement in male thalassemia major patients with arrested puberty and acquired hypogonadotropic hypogonadism (AAH): preliminary results and potential factors affecting induction of spermatogenesis","volume":"63","author":"De Sanctis","year":"2019","journal-title":"Endocrine"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)60382-5","article-title":"Induction of spermatogenesis in thalassaemia","volume":"50","author":"De Sanctis","year":"1988","journal-title":"Fertil Steril"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v90i3.8586","article-title":"Marital status and paternity in patients with transfusion- dependent thalassemia (TDT) and non transfusion-dependent thalassemia (NTDT): an ICET - a survey in different countries","volume":"90","author":"De Sanctis","year":"2019","journal-title":"Acta Biomed"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25608","article-title":"Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment","volume":"62","author":"Le","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12323","article-title":"The effect of hydroxcarbamide therapy on survival of children with sickle cell disease","volume":"161","author":"Lobo","year":"2013","journal-title":"Br J Haematol"},{"key":"B68","volume-title":"Evidence-based management of sickle cell disease: Expert panel report, 2014","year":"2014"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am J Hematol"},{"key":"B71","article-title":"Sickle cell disease in children","volume":"9","author":"Wang","year":"2011","journal-title":"Clin Adv Hematol Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. investigators of the multicenter study of hydroxyurea in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29423","article-title":"A call to start hydroxyurea by 6 months of age and before the advent of sickle cell disease complications","volume":"69","author":"Elenga","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"B74","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/sj.bmt.1704443","article-title":"Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome","volume":"33","author":"Brachet","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"B75","article-title":"Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients","volume":"89","author":"Yavarian","year":"2004","journal-title":"Haematologica"},{"key":"B76","first-page":"vii","article-title":"NTP-CERHR monograph on the potential human reproductive and developmental effects of hydroxyurea","author":"National Toxicology","year":"2008","journal-title":"NTP CERHR MON"},{"key":"B77","article-title":"Study of seminal fluid parameters and fertility of Male sickle cell disease patients and potential impact of hydroxyurea treatment","volume":"65","author":"Sahoo","year":"2017","journal-title":"J Assoc Physicians India"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13659","article-title":"Use of hydroxyurea from childhood to adult age in sickle cell disease: semen analysis","volume":"93","author":"Lukusa","year":"2008","journal-title":"Haematologica"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006270","article-title":"Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease","volume":"137","author":"Joseph","year":"2021","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.79","article-title":"Allogeneic cellular gene therapy in hemoglobinopathies\u2013evaluation of hematopoietic SCT in sickle cell anemia","volume":"47","author":"Lucarelli","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.01.009","article-title":"Current results and future research priorities in late effects after hematopoietic stem cell transplantation for children with sickle cell disease and thalassemia: A consensus statement from the second pediatric blood and marrow transplant consortium international conference on late effects after pediatric hematopoietic stem cell transplantation","volume":"23","author":"Shenoy","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.293","article-title":"Hemopoietic stem cell transplantation in thalassemia: a report from the European society for blood and bone marrow transplantation hemoglobinopathy registry, 2000-2010","volume":"51","author":"Baronciani","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bolanos-Meade","year":"2012","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.169581","article-title":"Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases","volume":"102","author":"Arnold","year":"2017","journal-title":"Haematologica"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309163291204","article-title":"Marrow transplantation in patients with thalassemia responsive to iron chelation therapy","volume":"329","author":"Lucarelli","year":"1993","journal-title":"N Engl J Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgi003","article-title":"Spermatogenesis after cancer treatment: damage and recovery","author":"Howell","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-62-743-995","article-title":"Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte","volume":"62","author":"Wallace","year":"1989","journal-title":"Br J Radiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.11.038","article-title":"Predicting age of ovarian failure after radiation to a field that includes the ovaries","volume":"62","author":"Wallace","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1136\/adc.66.4.517","article-title":"Gonadal function after allogenic bone marrow transplantation for thalassaemia","volume":"66","author":"De Sanctis","year":"1991","journal-title":"Arch Dis Child"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1701291","article-title":"Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium","volume":"22","author":"Vermylen","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e31806451ac","article-title":"Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation","volume":"29","author":"Brachet","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1080\/07357900902892780","article-title":"Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles","volume":"26","author":"Lukusa","year":"2009","journal-title":"Pediatr Hematol Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904971","article-title":"Allogeneic hematopoietic stem-cell transplantation for sickle cell disease","volume":"361","author":"Hsieh","year":"2009","journal-title":"N Engl J Med"},{"key":"B97","article-title":"Stem-cell transplantation for sickle cell disease","volume":"362","author":"Walters","year":"2010","journal-title":"N Engl J Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/bmt.2009.244","article-title":"Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience","volume":"45","author":"Majumdar","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.02.010","article-title":"Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease","volume":"19","author":"Dallas","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"B100","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.84","article-title":"Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease","volume":"49","author":"Bhatia","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12737","article-title":"Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients","volume":"165","author":"Dedeken","year":"2014","journal-title":"Br J Haematol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25059","article-title":"Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin","volume":"61","author":"Soni","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.188","article-title":"Targeted busulfan therapy with a steady-state concentration of 600-700 ng\/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant","volume":"49","author":"Maheshwari","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24183","article-title":"Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies","volume":"90","author":"King","year":"2015","journal-title":"Am J Hematol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.04.025","article-title":"Long-term follow-up after reduced-intensity conditioning and stem cell transplantation for childhood nonmalignant disorders","volume":"22","author":"Madden","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e2017014","DOI":"10.4084\/mjhid.2017.014","article-title":"Treosulfan-based conditioning regimen in sibling and alternative donor hematopoietic stem cell transplantation for children with sickle cell disease","volume":"9","author":"Marzollo","year":"2017","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.287","article-title":"Pregnancy outcome following hematopoietic cell transplantation for thalassemia major","volume":"52","author":"Santarone","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.183467","article-title":"Late effects after hematopoietic stem cell transplantation for beta-thalassemia major: the French national experience","volume":"103","author":"Rahal","year":"2018","journal-title":"Haematologica"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13496","article-title":"Adolescent male fertility following reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in non-malignant disorders","volume":"23","author":"Zhao","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001782","article-title":"Longitudinal description of gonadal function in sickle-cell patients treated with hematopoietic stem cell transplant using alkylator-based conditioning regimens","volume":"42","author":"Elchuri","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3324\/haematol.2018.213207","article-title":"Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France","volume":"105","author":"Bernaudin","year":"2020","journal-title":"Haematologica"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17311","article-title":"Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres","volume":"192","author":"Alzahrani","year":"2021","journal-title":"Br J Haematol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2021.0392","article-title":"Gonadal status and sexual function at long-term follow-up after allogeneic stem cell transplantation in adult patients with sickle cell disease","author":"Boga","year":"2022","journal-title":"Exp Clin Transplant"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.02.011","article-title":"Nonmyeloablative matched sibling donor hematopoietic cell transplantation in children and adolescents with sickle cell disease","volume":"25","author":"Guilcher","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.08.014","article-title":"Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease","volume":"21","author":"Al-Homsi","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.10.001","article-title":"Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-study","volume":"5","author":"Manger","year":"2006","journal-title":"Autoimmun Rev"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a019457","article-title":"Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy","volume":"11","author":"Blumenfeld","year":"1996","journal-title":"Hum Reprod"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950210505","article-title":"Ovarian function following the treatment of childhood acute lymphoblastic leukaemia","volume":"21","author":"Wallace","year":"1993","journal-title":"Med Pediatr Oncol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02267.x","article-title":"Sirolimus may reduce fertility in male renal transplant recipients","volume":"8","author":"Zuber","year":"2008","journal-title":"Am J Transplant"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-009-9644-8","article-title":"Gonadal dysfunction and infertility in kidney transplant patients receiving sirolimus","volume":"42","author":"Boobes","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-019-01462-5","article-title":"Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield","volume":"36","author":"Wald","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm11092318","article-title":"Fertility after curative therapy for sickle cell disease: A comprehensive review to guide care","volume":"11","author":"Nickel","year":"2022","journal-title":"J Clin Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23304","article-title":"Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions","volume":"58","author":"Hansbury","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0185","article-title":"Iatrogenic infertility after curative stem cell transplantation in patients with sickle cell disease","volume":"168","author":"Mishkin","year":"2018","journal-title":"Ann Intern Med"},{"key":"B126","article-title":"Fertility preservation in benign and malignant conditions","volume-title":"StatPearls","author":"Peterson","year":"2022"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.06.018","article-title":"Identifying at-risk populations: are we simply not doing enough fertility preservation procedures","volume":"110","author":"Flisser","year":"2018","journal-title":"Fertil Steril"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.10806","article-title":"Evaluation of reported fertility preservation counseling before chemotherapy using the quality oncology practice initiative survey","volume":"3","author":"Patel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/and.14020","article-title":"Access to male fertility preservation information and referrals at national cancer institute cancer centers","volume":"53","author":"Softness","year":"2021","journal-title":"Andrologia"},{"key":"B130","doi-asserted-by":"publisher","first-page":"100716","DOI":"10.1016\/j.gore.2021.100716","article-title":"Use of fertility preservation services in male reproductive-aged cancer patients","volume":"36","author":"Selter","year":"2021","journal-title":"Gynecol Oncol Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2022.01.235","article-title":"Impact of environmental and socioeconomic factors on semen quality in the united states","volume":"19","author":"Rabinowitz","year":"2022","journal-title":"J Sexual Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2019.01.027","article-title":"Distribution of semen parameters among adolescent males undergoing fertility preservation in a multicenter international cohort","volume":"127","author":"Halpern","year":"2019","journal-title":"Urology"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31255","article-title":"Fertility preservation options in pediatric and adolescent patients with cancer","volume":"124","author":"Burns","year":"2018","journal-title":"Cancer"},{"key":"B134","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/humrep\/dep371","article-title":"An experimental protocol for fertility preservation in prepubertal boys recently diagnosed with cancer: a report of acceptability and safety","volume":"25","author":"Ginsberg","year":"2010","journal-title":"Hum Reprod"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw029","article-title":"Cryopreservation of testicular tissue or testicular cell suspensions: a pivotal step in fertility preservation","volume":"22","author":"Onofre","year":"2016","journal-title":"Hum Reprod Update"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001618","article-title":"Reestablishment of spermatogenesis after more than 20 years of cryopreservation of rat spermatogonial stem cells reveals an important impact in differentiation capacity","volume":"20","author":"Whelan","year":"2022","journal-title":"PloS Biol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.854186","article-title":"Testicular tissue banking for fertility preservation in young boys: Which patients should be included","volume":"13","author":"Delgouffe","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1995.tb10840.x","article-title":"Diagnosis, prevention and management of ovarian hyperstimulation syndrome","volume":"102","author":"Brinsden","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.016","article-title":"Risks associated with fertility preservation for women with sickle cell anemia","volume":"110","author":"Pecker","year":"2018","journal-title":"Fertil Steril"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei268","article-title":"Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia: case report","volume":"21","author":"Donnez","year":"2006","journal-title":"Hum Reprod"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.12.022","article-title":"Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation","volume":"93","author":"Roux","year":"2010","journal-title":"Fertil Steril"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der063","article-title":"Micro-organ ovarian transplantation enables pregnancy: a case report","volume":"26","author":"Revel","year":"2011","journal-title":"Hum Reprod"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.09.029","article-title":"Live birth after orthotopic grafting of autologous cryopreserved ovarian tissue and spontaneous conception in Italy","volume":"99","author":"Revelli","year":"2013","journal-title":"Fertil Steril"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev128","article-title":"Live birth after autograft of ovarian tissue cryopreserved during childhood","volume":"30","author":"Demeestere","year":"2015","journal-title":"Hum Reprod"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2017-0410","article-title":"Ovarian tissue cryopreservation in young females through the oncofertility consortium's national physicians cooperative","volume":"14","author":"Armstrong","year":"2018","journal-title":"Future Oncol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-017-1008-1","article-title":"Acute pain crisis in a patient with sickle cell disease undergoing ovarian simulation for fertility preservation prior to curative stem cell transplantation: case report and literature review","volume":"34","author":"Matthews","year":"2017","journal-title":"J Assist Reprod Genet"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4784.18.04240-5","article-title":"Successful pregnancy in a woman previously suffering from beta-thalassemia following transplantation of ovarian tissue cryopreserved before puberty","volume":"70","author":"Matthews","year":"2018","journal-title":"Minerva Ginecol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.211094","article-title":"Post-transplant outcome of ovarian tissue cryopreserved after chemotherapy in hematologic malignancies","volume":"104","author":"Poirot","year":"2019","journal-title":"Haematologica"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.03.008","article-title":"Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers","volume":"115","author":"Dolmans","year":"2021","journal-title":"Fertil Steril"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.05.096","article-title":"Use of cryopreserved ovarian tissue in the Danish fertility preservation cohort","volume":"116","author":"Kristensen","year":"2021","journal-title":"Fertil Steril"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.xfre.2021.03.007","article-title":"Case report: two cases of mature oocytes found in prepubertal girls during ovarian tissue cryopreservation","volume":"2","author":"Hanfling","year":"2021","journal-title":"F S Rep"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"B153","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10815-019-01639-y","article-title":"Ovarian stimulation is a safe and effective fertility preservation option in the adolescent and young adult population","volume":"37","author":"Manuel","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew084","article-title":"The medical and ethical challenges of fertility preservation in teenage girls: a case series of sickle cell anaemia patients prior to bone marrow transplant","volume":"31","author":"Lavery","year":"2016","journal-title":"Hum Reprod"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3109\/03630260903365023","article-title":"Current perspectives of fertility and pregnancy in thalassemia","author":"Bajoria","year":"2009","journal-title":"Hemoglobin"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3109\/03630269.2011.623809","article-title":"Hypogonadotrophic hypogonadism and diminished gonadal reserve accounts for dysfunctional gametogenesis in thalassaemia patients with iron overload presenting with infertility","volume":"35","author":"Bajoria","year":"2011","journal-title":"Hemoglobin"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1614676","article-title":"Fertility preservation in women","volume":"377","author":"Donnez","year":"2017","journal-title":"N Engl J Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.04.050","article-title":"Importance of patient selection to analyze in vitro fertilization outcome with transplanted cryopreserved ovarian tissue","volume":"114","author":"Dolmans","year":"2020","journal-title":"Fertil Steril"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1177\/1933719117702251","article-title":"Current success and efficiency of autologous ovarian transplantation: A meta-analysis","volume":"24","author":"Pacheco","year":"2017","journal-title":"Reprod Sci"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-011-9698-2","article-title":"Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report","volume":"29","author":"Dovey","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13786","article-title":"Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis","volume":"123","author":"Boafor","year":"2016","journal-title":"BJOG"},{"key":"B162","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bpobgyn.2016.09.002","article-title":"Obstetric care for women with thalassemia","volume":"39","author":"Lao","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13270","article-title":"Pregnancy outcome in patients with sickle cell disease in the UK\u2013a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease","volume":"169","author":"Oteng-Ntim","year":"2015","journal-title":"Br J Haematol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-607317","article-title":"Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis","volume":"125","author":"Oteng-Ntim","year":"2015","journal-title":"Blood"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199402000-00025","article-title":"Beta-thalassemia syndromes and pregnancy","volume":"49","author":"Savona-Ventura","year":"1994","journal-title":"Obstet Gynecol Surv"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000127433.23611.54","article-title":"Outcome of pregnancy in homozygous sickle cell disease","volume":"103","author":"Serjeant","year":"2004","journal-title":"Obstet Gynecol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.115477","article-title":"Sickle cell disease in pregnancy: twenty years of experience at Grady memorial hospital, Atlanta, Georgia","volume":"184","author":"Sun","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1177\/003591576706000704","article-title":"The management of anaesthesia in sickle cell states","volume":"60","author":"Gilbertson","year":"1967","journal-title":"Proc R Soc Med"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3182a44d74","article-title":"Surgical procedures and outcomes among children with sickle cell disease","volume":"117","author":"Hyder","year":"2013","journal-title":"Anesth Analg"},{"key":"B170","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ajh.25626","article-title":"Perioperative care of children with sickle cell disease: A systematic review and clinical recommendations","volume":"95","author":"Schyrr","year":"2020","journal-title":"Am J Hematol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/bdrb.20123","article-title":"NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea","volume":"80","author":"Liebelt","year":"2007","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"B172","article-title":"Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the national preoperative transfusion study. preoperative transfusion in sickle cell disease study group","volume":"89","author":"Haberkern","year":"1997","journal-title":"Blood"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"key":"B174","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V86.10.3676.bloodjournal86103676","article-title":"Surgery and anesthesia in sickle cell disease. cooperative study of sickle cell diseases","volume":"86","author":"Koshy","year":"1995","journal-title":"Blood"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199911)62:3<129::AID-AJH1>3.0.CO;2-J","article-title":"The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the national sickle cell surgery study group","volume":"62","author":"Vichinsky","year":"1999","journal-title":"Am J Hematol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199903000-00009","article-title":"Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. preoperative transfusion in sickle cell disease study group","volume":"21","author":"Waldron","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-9684(15)31410-3","article-title":"Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease","volume":"100","author":"Darbari","year":"2008","journal-title":"J Natl Med Assoc"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079923","article-title":"Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study","volume":"8","author":"Darbari","year":"2013","journal-title":"PloS One"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. the preoperative transfusion in sickle cell disease study group","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1611","article-title":"Sickle cell disease: a question of equity and quality","volume":"117","author":"Smith","year":"2006","journal-title":"Pediatrics"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.01.005","article-title":"Hematopoietic cell transplantation and utilization of fertility preservation services","volume":"25","author":"Hwee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2009.09.007","article-title":"Impact of physicians' personal discomfort and patient prognosis on discussion of fertility preservation with young cancer patients","volume":"77","author":"Quinn","year":"2009","journal-title":"Patient Educ Couns"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.0250","article-title":"Physician referral for fertility preservation in oncology patients: a national study of practice behaviors","volume":"27","author":"Quinn","year":"2009","journal-title":"J Clin Oncol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jadohealth.2008.08.014","article-title":"Fertility preservation and adolescent\/young adult cancer patients: physician communication challenges","volume":"44","author":"Quinn","year":"2009","journal-title":"J Adolesc Health"},{"key":"B186","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1093\/humrep\/des339","article-title":"Cost-effective analysis of oocyte cryopreservation: stunning similarities but differences remain","volume":"27","author":"Hirshfeld-Cytron","year":"2012","journal-title":"Hum Reprod"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djx006","article-title":"Woodruff TK. A call for fertility preservation coverage for breast cancer patients: The cost of consistency","volume":"109","author":"Walter","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"B188","unstructured":"2022"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6518-9_37","article-title":"The role of a patient navigator in fertility preservation","volume":"156","author":"Scott-Trainer","year":"2010","journal-title":"Cancer Treat Res"},{"key":"B190","article-title":"Addressing barriers to fertility preservation for cancer patients: The role of oncofertility patient navigation","volume":"12","author":"Dorfman","year":"2021","journal-title":"J Oncol Navig Surviv"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.985525\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T10:39:37Z","timestamp":1666607977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.985525\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":190,"alternative-id":["10.3389\/fendo.2022.985525"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.985525","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"article-number":"985525"}}